These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8338940)

  • 21. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
    Erickson PF; Robinson M; Owens G; Drabkin HA
    Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).
    Vieira L; Oliveira V; Ambrósio AP; Marques B; Pereira AM; Hagemeijer A; Boavida MG
    Cancer Genet Cytogenet; 2001 Jul; 128(2):104-7. PubMed ID: 11463447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia.
    Yamasaki H; Era T; Asou N; Sanada I; Matutes E; Yamaguchi K; Takatsuki K
    Leukemia; 1995 Jul; 9(7):1147-53. PubMed ID: 7630188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping.
    Miyagi J; Kakazu N; Masuda M; Miyagi T; Toyohama T; Nakazato T; Tomoyose T; Shinjyo T; Nagasaki A; Taira N; Ohki M; Abe T; Takasu N
    Int J Hematol; 2002 Nov; 76(4):338-43. PubMed ID: 12463597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocation(8;20;21)(q22;q13;q22) in acute myeloblastic leukemia with maturation: a variant form of t(8;21).
    Wong KF; Kwong YL; So CC
    Cancer Genet Cytogenet; 1998 Feb; 101(1):39-41. PubMed ID: 9460498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
    Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y
    Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
    Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
    Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
    Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21).
    Tobal K; Yin JA
    Blood; 1996 Nov; 88(10):3704-9. PubMed ID: 8916934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22).
    Kawakami K; Nishii K; Hyou R; Watanabe Y; Nakao M; Mitani H; Murata T; Monma F; Yamamori S; Hosokai N; Miura I
    Int J Hematol; 2008 Jan; 87(1):78-82. PubMed ID: 18224418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
    Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.
    Mitterbauer M; Kusec R; Schwarzinger I; Haas OA; Lechner K; Jaeger U
    Ann Hematol; 1998; 76(3-4):139-43. PubMed ID: 9619731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex t(8;13;21)(q22;q14;q22)--a novel variant of t(8;21) in a patient with acute myeloid leukemia (AML-M2).
    Udayakumar AM; Alkindi S; Pathare AV; Raeburn JA
    Arch Med Res; 2008 Feb; 39(2):252-6. PubMed ID: 18164974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase.
    Saunders MJ; Tobal K; Keeney S; Liu Yin JA
    Leukemia; 1996 Jul; 10(7):1139-42. PubMed ID: 8683993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
    Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
    Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
    Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
    Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
    Farra C; Awwad J; Valent A; Lozach F; Bernheim A
    Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.